De Yong Wen
Director Ejecutivo en SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. .
Fortuna: 638 873 $ al 30/04/2025
Perfil
De Yong Wen currently works at Shanghai Fosun Pharmaceutical (Group) Co., Ltd., as Vice Chairman & Co-Chief Executive Officer from 2025, China National Accord Medicines Corp.
Ltd., as Chairman-Supervisory Board from 2019, Sinopharm Group Co., Ltd., as Non-Executive Director from 2017, China National Medicines Co., Ltd., as Director from 2019, Sinopharm Industrial Investment Co., Ltd., as Director from 2020, and Shanghai Henlius Biotech, Inc., as Non-Executive Director from 2022.
Mr. Wen also formerly worked at Chongqing Yao Pharmaceutical Co., Ltd., as Vice Chairman and C.Q.
Pharmaceutical Holding Co., Ltd., as Director.
Mr. Wen received his Masters Business Admin degree in 2007 from Donghua University and undergraduate degree in 1995 from West China University of Medical Sciences.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
31/12/2023 | 187.100 ( 9,5 % ) | 602 817 $ | 30/04/2025 | |
31/12/2024 | 20.000 ( 0 % ) | 36 056 $ | 30/04/2025 |
Cargos activos de De Yong Wen
Empresas | Cargo | Inicio |
---|---|---|
SINOPHARM GROUP CO. LTD. | Director/Miembro de la Junta | 01/09/2017 |
CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Miembro de la Junta | 09/05/2019 |
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Director Ejecutivo | 01/06/2022 |
SHANGHAI HENLIUS BIOTECH, INC. | Director/Miembro de la Junta | 28/07/2022 |
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Presidente | 10/07/2019 |
Sinopharm Industrial Investment Co., Ltd.
![]() Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | 20/01/2020 |
Antiguos cargos conocidos de De Yong Wen.
Empresas | Cargo | Fin |
---|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
![]() Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Director/Miembro de la Junta | - |
C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Director/Miembro de la Junta | - |
Formación de De Yong Wen.
West China University of Medical Sciences | Undergraduate Degree |
Donghua University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 6 |
---|---|
C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Health Technology |
SINOPHARM GROUP CO. LTD. | Distribution Services |
CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Health Technology |
Empresas privadas | 2 |
---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
![]() Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Health Technology |
Sinopharm Industrial Investment Co., Ltd.
![]() Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Finance |
- Bolsa de valores
- Insiders
- De Yong Wen